BioRem Inc.

BRM.V · TSXV
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
9/30/2025
6/30/2025
3/31/2025
12/31/2024
RevenueCA$11,253CA$9,431CA$4,730CA$9,315
% Growth19.3%99.4%-49.2%–
Cost of Goods SoldCA$8,087CA$6,881CA$3,621CA$7,718
Gross ProfitCA$3,166CA$2,550CA$1,110CA$1,597
% Margin28.1%27%23.5%17.1%
R&D ExpensesCA$49CA$16CA$14CA$7
G&A ExpensesCA$474CA$949CA$457CA$395
SG&A ExpensesCA$1,521CA$1,476CA$1,023CA$1,295
Sales & Mktg Exp.CA$1,047CA$528CA$565CA$901
Other Operating Expenses-CA$18CA$4-CA$21CA$8
Operating ExpensesCA$1,553CA$1,496CA$1,016CA$1,311
Operating IncomeCA$1,613CA$1,054CA$94CA$287
% Margin14.3%11.2%2%3.1%
Other Income/Exp. Net-CA$38-CA$41-CA$44-CA$47
Pre-Tax IncomeCA$1,575CA$1,013CA$51CA$240
Tax ExpenseCA$417CA$269CA$13CA$69
Net IncomeCA$1,158CA$745CA$37CA$171
% Margin10.3%7.9%0.8%1.8%
EPS0.0720.0470.0020.011
% Growth54.8%2,225%-81.1%–
EPS Diluted0.0620.040.002-0.023
Weighted Avg Shares Out16,00616,03018,58216,137
Weighted Avg Shares Out Dil18,63018,60618,58215,659
Supplemental Information––––
Interest IncomeCA$0CA$0CA$0CA$0
Interest ExpenseCA$38CA$41CA$44CA$47
Depreciation & AmortizationCA$133CA$109CA$134CA$140
EBITDACA$1,746CA$1,163CA$229CA$427
% Margin15.5%12.3%4.8%4.6%